Additionally, this paper will analyze the therapeutic effects of chemotherapy, targeted therapy, and immunotherapy in clinical practice and look to provide individualized treatment strategies for patients with KRAS mutations in lung cancer. This evidence concerns the gene KRAS and lung cancer.